more

Walgreens Boots Alliance (WBA)

(Delayed Data from NSDQ)

$9.01 USD

-0.38 (-4.05%)

Updated Nov 12, 2024 04:00 PM ET

After-Market: $9.02 +0.01 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

Bottom 9% (226 out of 249)

Industry: Retail - Pharmacies and Drug Stores

View All Zacks #1 Ranked Stocks

Zacks News

Here's Why You Should Hold on to Walgreens Boots (WBA) For Now

by Zacks Equity Research Published on April 11,2022

Investors are optimistic about Walgreens (WBA) owing to the recent product launches.

Walgreens (WBA) Expands Medical Care Offerings in California

by Zacks Equity Research Published on April 07,2022

Walgreens' (WBA) new initiative is intended to reduce care gaps and advance care management by providing access to more affordable and convenient services.

Company News for Apr 1, 2022

by Zacks Equity Research Published on April 01,2022

Companies In The News Are: WBA, XOM, JPM, VNET.

Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Up

by Zacks Equity Research Published on April 01,2022

Strong execution across business segments, led by COVID-19 vaccinations and testing, drove Walgreens' (WBA) fiscal second-quarter top line.

Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on March 31,2022

Walgreens (WBA) delivered earnings and revenue surprises of 14.39% and 0.19%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?

Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview

by Zacks Equity Research Published on March 28,2022

Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview.

Breaking Down the Outlook for S&P 500 Margins

by Sheraz Mian Published on March 25,2022

Revisions to the 2022 Q1 estimates are mixed, with estimates for 9 of the 16 Zacks sectors going down since the start of January, with the Consumer Discretionary, Transportation and Aerospace sectors suffering significant estimate cuts...

Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know

by Zacks Equity Research Published on March 22,2022

Walgreens Boots Alliance (WBA) closed at $47.43 in the latest trading session, marking a +0.11% move from the prior day.

WBANegative Net Change

Walgreens (WBA), Village MD Plan to Expand Into New Hampshire

by Zacks Equity Research Published on March 21,2022

Walgreens (WBA) and VillageMD are working together to make it easier for the communities to access high-quality, coordinated primary care and pharmacy services.

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

by Urmimala Biswas Published on March 21,2022

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most. However, reimbursement challenges are hurting the industry's health.

Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know

by Zacks Equity Research Published on March 15,2022

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.17, marking a +0.54% move from the previous day.

WBANegative Net Change

Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know

by Zacks Equity Research Published on March 09,2022

Walgreens Boots Alliance (WBA) closed at $48.12 in the latest trading session, marking a +1.37% move from the prior day.

WBANegative Net Change

Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp

by Zacks Equity Research Published on March 08,2022

Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.